- San Diego Biotechnology Network - http://sdbn.org -
SDBN July 21st Event Featuring Fate Therapeutics and Stemgent
Posted By Mary Canady On June 15, 2009 @ 3:06 pm In SDBN Blog,SDBN Events,SDBN Feed | No Comments
|The San Diego Biotechnology Network is pleased to feature Fate Therapeutics and Stemgent at our July 21st networking event. These two companies represent exciting, interdisciplinary biotechnology research being done in San Diego that holds direct promise for making a difference in our quality of life. The event will feature a short talk followed by networking with the speakers and scientists from the two companies. As usual, we hope that the casual atmosphere at our venue, Tango del Rey, will stimulate discussions and meaningful interactions for all in attendance. We also encourage you to utilize the online tools available to communicate before, during, and after the event.|| 
Dan Shoemaker, Ph.D., CTO (Fate), Stephen Chang, Ph.D., CSO (Stemgent) will present a short talk describing CATALYST:
Fate Therapeutics is interrogating adult stem cell biology and applying induced pluripotent stem cell (iPSC) technology to develop Stem Cell Modulators (SCMs), small molecule or biologic compounds that guide cell fate for therapeutic purposes. Fate’s approach has broad therapeutic potential in areas such as regenerative medicine, hematological diseases, metastatic cancer, traumatic injury and degenerative diseases. In addition, Fate Therapeutics and Stemgent have formed an alliance – Catalyst – a collaborative program to provide Catalyst Members with first access to the most advanced iPSC technologies for drug discovery and development. Fate Therapeutics is headquartered in La Jolla, CA. For more information, please visit http://www.fatetherapeutics.com .
Stemgent helps our customers advance stem cell science by providing proprietary reagents and technologies developed by some of the world’s leading stem cell scientists. Stemgent’s product offering includes virus-delivered reprogramming factors for iPS cell generation, cytokines and matrices for healthy stem cell growth, primary and reporter cell lines, stem cell characterization tools, polymers for transfection, and small molecules for reprogramming, self-renewal and differentiation. This unique product mix is designed to serve researchers who study stem cell biology and regenerative medicine, and those who use cells derived from stem cells to advance their understanding of major diseases. For more information visit us at www.stemgent.com .
Who: Biotechnology professionals in the greater San Diego area
What: San Diego Biotechnology Network’s July Networking Event Featuring Fate Therapeutics and Stemgent
When: Tuesday, July 21st, 5:30-9:00 p.m.
Where: Tango Del Rey, 3567 Del Rey Street, San Diego 92109 (Directions below)
Cost: $20, including appetizers ($15 for Academics) +$5 at door
Contact: http://sdbn.org/contact 
For more information about the event: http://sdbn.org/july 
Directions: From the North: South on Interstate 5, Exit Balboa Ave, Straight to 4th Traffic Light then left on Bunker Hill St. Building directly ahead 3 blks. From the South: North on Interstate 5, Exit Grand/ Garnet Ave, Straight to 3rd Traffic Light then right on Bunker Hill St. Building directly ahead 3 blks.
Article printed from San Diego Biotechnology Network: http://sdbn.org
URL to article: http://sdbn.org/2009/06/15/sdbn-july-event/
URLs in this post:
 Image: http://www.fatetherapeutics.com
 Image: http://www.stemgent.com
 http://sdbn.org/contact: http://sdbn.org/contact
 http://sdbn.org/july: http://sdbn.org/july
 Image: http://sdbn.org/register
Copyright © 2008-2010 Comprendia, LLC. All rights reserved.